NCT04939493 is a NA clinical trial of Rhythmic Auditory Cueing in Hemiplegia, Spastic, sponsored by Cairo University.

Who is sponsoring NCT04939493?

NCT04939493 is sponsored by Cairo University.

What drugs are being tested in NCT04939493?

Interventions in NCT04939493: Rhythmic Auditory Cueing, Bilateral arm training, Conventional physical therapy program.

What condition does NCT04939493 study?

NCT04939493 studies Hemiplegia, Spastic.

Is NCT04939493 still recruiting?

NCT04939493 is currently completed. Last updated 25 June 2021.

Last reviewed 2021-06-25 · How we verify

NCT04939493

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Use of Rhythmic Auditory Cueing During Bilateral Training of the Upper Extremities in Stroke Patients

Completed NA Last updated 25 June 2021

What this trial tests

NA trial testing Rhythmic Auditory Cueing in Hemiplegia, Spastic in 30 participants. Completed in 15 June 2021.

Timeline

1 January 2021

Primary endpoint
30 May 2021

15 June 2021

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	30
Start date	1 January 2021
Primary completion	30 May 2021
Estimated completion	15 June 2021
Sites	1 location across Egypt

Drugs / interventions tested

Rhythmic Auditory Cueing
Bilateral arm training
Conventional physical therapy program

Conditions studied

Hemiplegia, Spastic — all drugs for Hemiplegia, Spastic →

Sponsor

Cairo University

Who can join

Adults 45 to 60, any sex, with Hemiplegia, Spastic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to determine the effect of rhythmic auditory cueing with bilateral arm training on upper limb functions in stroke patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04939493 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 25 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04939493.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing